STOCK TITAN

[SCHEDULE 13G/A] CareDx, Inc. Amended Passive Investment Disclosure

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

CareDx Inc Schedules an Amendment No. 9 to a Schedule 13G/A showing 0 shares beneficially owned, representing 0% of Common Stock as of 03/13/2026.

The filing explains an internal realignment at The Vanguard Group on 01/12/2026, after which certain Vanguard subsidiaries report holdings separately in reliance on SEC Release No. 34-39538. The filing is signed by a Vanguard officer on 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports no beneficial ownership after organizational realignment.

The amendment states 0 shares beneficially owned and 0% of the class as of 03/13/2026, reflecting a reporting change tied to Vanguard's internal realignment on 01/12/2026.

Practical implications depend on which Vanguard subsidiaries now report separately; subsequent filings may disclose subsidiary-level positions and any trading activity affecting stake visibility.

Disclosure follows SEC Release No. 34-39538 guidance on disaggregated reporting.

The statement cites SEC Release No. 34-39538 and explains that certain subsidiaries will report separately, removing aggregated beneficial ownership from The Vanguard Group.

This is a compliance-driven amendment; any material ownership that could affect governance will appear in future separate Schedule 13 filings by those subsidiaries.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026
Caredx

NASDAQ:CDNA

View CDNA Stock Overview

CDNA Rankings

CDNA Latest News

CDNA Latest SEC Filings

CDNA Stock Data

925.99M
48.89M
Diagnostics & Research
Services-medical Laboratories
Link
United States
BRISBANE